Genomic sequencing for covid-19
Ended Definitive Contract Awarded Last action
- Contract number
- 75D30122C13720
- Awardee
-
Helix Opco LLC UEI EVK2ALWXCT21
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- -$41,088,390
Award facts
- Opportunity
-
- 75D30122Q74743 Solicitation number
- Contract value 0% obligated
- $13,506,150.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- 23 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Mateo, CA 94401, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$68,385,660 | |
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $18,198,180 | |
| Exercise an Option | $27,297,270 | |
| Original award | $36,396,360 |
About this award
The Centers for Disease Control and Prevention (CDC) awarded Helix Opco LLC a definitive contract valued at $13.5 million for genomic sequencing services related to COVID-19 tracking and research efforts. The contract, awarded on May 16, 2022, with an ultimate completion date of April 28, 2025, utilizes firm fixed-price pricing with no set-aside designation. Work will be performed at Helix Opco's facility in San Mateo, California. This award supports the CDC's ongoing public health surveillance and genomic analysis capabilities, which have been critical infrastructure for monitoring virus variants and informing pandemic response strategies since the emergence of COVID-19.
Helix Opco is an established provider of genomic sequencing and advanced diagnostics services to federal public health agencies, with a track record of managing multi-million dollar contracts for the CDC and National Institutes of Health (NIH). The contractor's experience includes COVID-19 sample processing and genomic analysis work, positioning it to deliver the sequencing capabilities required under this contract. The award was subject to termination for convenience provisions and was part of a broader government initiative to implement cost efficiency measures across federal spending.
Quick answers
Who was awarded contract 75D30122C13720?
75D30122C13720 was awarded to Helix Opco LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on May 16, 2022.
How much is contract 75D30122C13720 worth?
The government has obligated -$41,088,390 on 75D30122C13720. Its current value, with exercised options, is $13,506,150.
Was contract 75D30122C13720 competed?
The government received 23 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award